Checkpoint immunotherapies have emerged as the first effective treatment option for patients with advanced basal cell carcinoma, squamous cell carcinoma, and melanoma. Help CRI scientists explore ways to extend these benefits to even more skin cancer patients.
Monthly donations help us plan and allocate resources effectively to advance research and save more lives.
I would like to create a card as part of my donation.
I want to receive the latest cancer immunotherapy news.
Find out if your employer will match your donation:
By clicking I agree to the terms & conditions
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442.Donations are tax-deductible to the fullest extent allowable under the law.